Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Improving Care for Frail Older Adults Using a Digital Needs Assessment Tool (Frailty)

5 mai 2026 mis à jour par: Angelique Chan, Duke-NUS Graduate Medical School

Integrating Health and Social Service Needs for Frail Elders at Point of Care: Development and Evaluation of an IT-based Digital Needs-assessment Tool

The goal of this trial is to evaluate whether a digital needs-assessment tool can improve care planning and outcomes for frail older adults (aged 60 years and above) hospitalized in Singapore. The tool is designed to identify patients' health and social service needs and support better care coordination after hospital discharge.

The main questions it aims to answer are:

  • Does the use of a digital needs-assessment tool improve the identification and management of health and social service needs in frail older adults?
  • Does this approach improve patient outcomes, such as quality of life, care satisfaction, and healthcare utilization after discharge?

Participants will:

  • Respond to a baseline questionnaire
  • Receive a personalized care plan based on identified needs by the tool
  • Be followed up at 1 month and 3 months after discharge through surveys
  • Some participants will receive additional follow-up phone calls to review care needs and service use
  • A subset of participants will take part in interviews to share their care experiences

Aperçu de l'étude

Description détaillée

Older adults with frailty frequently experience multiple medical, functional, and social challenges following hospital discharge. Evidence from the Health and Social Service Needs study indicates that patients discharged with unmet health and health-related social service (HASS) needs have poorer post-discharge outcomes, including increased healthcare utilization. While frailty screening is commonly used to identify high-risk patients, frailty status alone does not identify the specific actionable needs that could mitigate health deterioration or support community living.

During hospitalization, assessments of these needs are typically conducted through referrals to medical social workers, patient navigators, case managers, or geriatricians. These referrals are discretionary and vary across providers and settings, contributing to inconsistent care delivery. Such approaches are resource-intensive and difficult to sustain under workforce constraints and may lead to missed identification of needs or delays in discharge, increasing the risk of unmet needs during care transitions.

This study evaluates the implementation of a needs-based assessment approach using the Simple Segmentation Tool (SST), a brief digital instrument developed in Singapore by Matchar et al. (2017). The SST is designed to rapidly identify likely actionable HASS needs and support care planning and referral processes. The tool can be completed in approximately 2-3 minutes by trained healthcare professionals, including physicians, nurses, and case managers, and is supported by an algorithm developed by a multidisciplinary expert panel.

Following enrollment, hospital staff will complete the SST based on participants' clinical and social circumstances. Care plans will be generated using outputs from the SST and reviewed with participants and/or their caregivers. If a participant is readmitted within three weeks of discharge, the SST assessment will be repeated following the subsequent discharge to ensure that care plans reflect updated or evolving needs. Participants who decline recommended services will remain enrolled in the study but will not be counted toward the target sample size of 200 participants.

Participants will complete a baseline questionnaire during hospitalization and will be followed after discharge with structured surveys administered at one month and three months. These surveys will assess post-discharge outcomes related to health status, care experiences, and healthcare utilization. Qualitative interviews will also be conducted with a subset of patients and healthcare staff to explore experiences, perceived value, and implementation challenges associated with SST-guided care planning.

To support care coordination, internal stakeholders and external community service providers, coordinated by the Agency for Integrated Care Care-Referral Team, will use a shared framework to facilitate service linkage and care transitions. Service activation and follow-up will be tracked, and any failures in linkage will be communicated to a central coordinating team to support resolution and continuity of care.

Prior to the main study, a pilot phase involving up to 10 patient volunteers will be conducted to assess workflow feasibility, clarity of study materials, and questionnaire length. Pilot participants will provide informed consent, and data collected during this phase will not be included in research analyses. Feedback from the pilot will be used to refine study procedures and materials prior to full implementation.

Type d'étude

Interventionnel

Inscription (Estimé)

200

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Shenglin Zheng, Ph.D.
  • Numéro de téléphone: 6580325886
  • E-mail: sz61@nus.edu.sg

Lieux d'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte
  • Adulte plus âgé

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Patient participant: (i) Aged >= 60 years at the time of recruitment; (ii) identified as frail, with a CFS score >= 5 and/or modified HFRS intermediate and high frailty risk (mHFRS) score >=5; (iii) Singapore citizens or permanent residents; (iv) able to speak and understand English, Chinese or Malay.
  • Proxy (when responding on behalf of eligible patients): (i) Relative or friend of the patient participant; (ii) Aged 21 years or older; (iii) Familiar with the older adult's health and social situation.

Exclusion Criteria:

  • Patient participant: (i) Currently involved in another study or (ii) residents of nursing homes, or (iii) patients known to home hospice or home palliative care services with a life expectancy of less than 6 months.
  • Proxy: primary caregivers who are foreign domestic workers will be excluded from the study.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Recherche sur les services de santé
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: SST + care coordination calls
Participants will receive a digital needs assessment during hospitalization and a personalized care plan. After discharge, participants will be randomized in a 1:3 ratio. Participants will receive two follow-up calls from care coordinators to review care needs and support care coordination.
The Simple Segmentation Tool (SST) is used to assess multidimensional needs and generate individualized care recommendations. Participants receive SST-informed care plan and referral to appropriate health and social services.
Participants will receive two structured post-discharge care coordination phone calls to support service uptake, address barriers, and facilitate follow-up on recommended services.
Expérimental: SST only
Participants will receive a digital needs assessment during hospitalization and a personalized care plan.
The Simple Segmentation Tool (SST) is used to assess multidimensional needs and generate individualized care recommendations. Participants receive SST-informed care plan and referral to appropriate health and social services.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Service initiation rate
Délai: 30 days after discharge
The proportion of enrolled participants who successfully initiate at least one recommended health or social support service
30 days after discharge

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Health-related quality of life
Délai: Baseline, 1-month and 3-month follow-ups
Change in health-related quality of life measured using the 5-level EQ-5D (EQ-5D-5L). The EQ-5D-5L essentially consists of the EQ-5D descriptive system, where Index Score calculated based on country-specific preference (Singapore in this context) and the EuroQol Visual Analogue Scale (EQ-VAS) (range: 0 to 100) were reported. For both measures, higher scores indicate better health-related quality of life.
Baseline, 1-month and 3-month follow-ups
Healthcare Utilisation
Délai: 180 days and 360 days post-discharge
Healthcare service utilisation obtained from electronic medical records (EMR), including number of emergency department visits, hospital admissions, outpatient visits, and visits to healthcare professionals.
180 days and 360 days post-discharge
Usability of SST
Délai: 24 hours after the first administered SST
Usability was measured using the System Usability Scale (SUS), a 10-item instrument providing a global score from 0 to 100. Higher scores indicate better perceived usability.
24 hours after the first administered SST
Intervention appropriateness (implementation outcome)
Délai: 3-month follow-up
Assessed using the Intervention Appropriateness Measure (IAM) among staff involved in the care of patients using the SST, with total scores ranging from 4-20. Higher scores indicate greater appropriateness.
3-month follow-up
Quality of care and continuity
Délai: 1-month and 3-month follow-ups
Quality of care and continuity is measured using the adaptive Patient Continuity of Care Checklist (PCCQ). Items are rated on a 5-point Likert scale and scores range from 5-30. Higher scores indicate a higher level of perceived continuity of care.
1-month and 3-month follow-ups
Mortality
Délai: 180 and 360 days post-discharge
All-cause mortality assessed using electronic medical records (EMR), defined as death occurring from the time of enrollment.
180 and 360 days post-discharge
Service quality of SST
Délai: 24 hours after the first administered SST
Perceived service quality was measured using an adaptive Electronic Service Quality Scale (E-S-QUAL) consisting of 19 items. Respondents first distributed 100 points across the four dimensions Efficiency, Fulfillment, System Availability, and Privacy, to reflect relative importance. Items were then rated on a 5-point Likert scale. Higher scores indicating a better perception of electronic service quality.
24 hours after the first administered SST
Care experience
Délai: 1-month and 3-month follow-ups
Patient-reported experience is measured using Client Satisfaction Questionnaire (CSQ-4). Total scores range from 4 to 16, where higher scores indicate greater satisfaction with care.
1-month and 3-month follow-ups
Intervention feasibility (implementation outcome)
Délai: 3-month follow-up
Assessed using the Feasibility of Intervention Measure (FIM) among staff involved in the care of patients using the SST. Total scores range from 4-20 and higher scores indicate greater feasibility.
3-month follow-up
Normalization process (implementation outcome)
Délai: 3-month follow-up
Assessed using the Normalisation Measure Development (NoMAD) among staff involved in the care of patients using the SST. Total scores range from 0-100. Higher scores indicate better normalization.
3-month follow-up
Intervention acceptability (implementation outcome)
Délai: 3-month follow-up
Measured by the Acceptability of Intervention Measure (AIM)among staff involved in the care of patients using the SST, with a total score ranging from 4-20. Higher scores indicate greater acceptability.
3-month follow-up

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Healthcare costs
Délai: 180 and 360 days post-discharge
Healthcare utilisation costs and billing data obtained from EMR, including hospital and outpatient service costs.
180 and 360 days post-discharge
Unmet needs and service utilization
Délai: 1-month and 3-month follow-ups
Assessment of assistance participants received since the last hospital discharge (18-item)
1-month and 3-month follow-ups
Caregiver burden (proxy participants only)
Délai: Baseline, 1-month and 3-month follow-ups
Caregiver burden measured using the 4-item Zarit Burden Interview, administered to proxies who are primary caregivers.
Baseline, 1-month and 3-month follow-ups
Resilience
Délai: Baseline, 1-month and 3-month follow-ups
Change in psychological resilience measured using the Connor-Davidson Resilience Scale (CD-RISC 10), with total scores ranging from 0 from 4. Higher scores indicate a higher level of psychological resilience.
Baseline, 1-month and 3-month follow-ups
Social support
Délai: Baseline, 1-month and 3-month follow-ups
Change in social connectedness and support measured using the Lubben Social Network Scale-Revised (LSNS-R), with total scores ranging from 0 to 60. Higher scores indicate a larger and more robust social network.
Baseline, 1-month and 3-month follow-ups
Depressive symptoms
Délai: Baseline, 1-month and 3-month follow-ups
Change in depressive symptoms measured using the Patient Health Questionnaire-2 (PHQ-2) with total scores ranging from 0 to 6. Higher scores indicate a greater likelihood of depressive symptoms.
Baseline, 1-month and 3-month follow-ups
Loneliness
Délai: Baseline, 1-month and 3-month follow-ups
Change in loneliness using the Three-Item Loneliness Scale, with total scores ranging from 3 to 9. Higher scores indicate a greater perception of loneliness.
Baseline, 1-month and 3-month follow-ups
Physical activity
Délai: Baseline, 1-month and 3-month follow-ups
Change in physical activity levels measured using the Physical Activity Scale for the Elderly (PASE).
Baseline, 1-month and 3-month follow-ups
Instrumental Activities of Daily Living
Délai: Baseline, 1-month and 3-month follow-ups
Change in functional ability measured using Lawton Instrumental Activities of Daily Living (IADL), with total scores ranging from 0-16. Higher scores indicate greater functional independence.
Baseline, 1-month and 3-month follow-ups
Activities of Daily Living
Délai: Baseline, 1-month and 3-month follow-ups
Change in functional ability measured using Katz Index of Independence in Activities of Daily Living (ADL), with total scores ranging from 0-12. Higher scores indicate greater functional independence.
Baseline, 1-month and 3-month follow-ups

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Angelique Chan, Ph.D., Duke-NUS Graduate Medical School

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 mai 2026

Achèvement primaire (Estimé)

30 décembre 2026

Achèvement de l'étude (Estimé)

30 décembre 2027

Dates d'inscription aux études

Première soumission

14 avril 2026

Première soumission répondant aux critères de contrôle qualité

5 mai 2026

Première publication (Réel)

12 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

12 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • CIRB: 2024-2130
  • MOH-001199-00 (Autre subvention/numéro de financement: National Research Foundation (NRF), Singapore)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner